Ignite Creation Date:
2025-12-24 @ 12:19 PM
Ignite Modification Date:
2025-12-27 @ 9:32 PM
Study NCT ID:
NCT01637961
Status:
COMPLETED
Last Update Posted:
2019-07-23
First Post:
2012-07-08
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Alisertib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-08
Start Date Type:
None
Primary Completion Date:
2014-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-02-11
Completion Date Type:
ACTUAL
First Submit Date:
2012-07-08
First Submit QC Date:
None
Study First Post Date:
2012-07-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-04-29
Results First Submit QC Date:
None
Results First Post Date:
2015-07-17
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-07-22
Last Update Post Date:
2019-07-23
Last Update Post Date Type:
ACTUAL